Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000577:Amides / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D000882:Haplorhini; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006614:Hindlimb / Q000098:blood supply; D007211:Indoles / Q000494:pharmacology*; D008012:Lidocaine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000577:Amides; D007211:Indoles; D010880:Piperidines; D013565:Sympatholytics; D008012:Lidocaine; D011433:Propranolol